308. Progressive leukoencephalopathy Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 4 / Drugs : 4 - (DrugBank : 1) / Drug target genes : 5 - Drug target pathways : 2
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Fosigotifator
Calico Life Sciences LLC
2023 Phase 1/Phase 2 NCT05757141 Canada;Netherlands;United States
McGill University Health Centre/Research Institute of the McGill University Health Centre
2025 - NCT07300397 Canada
2024 Early Phase 1 NCT07272525 Canada
Hematopoetic stem cell transplantation
University of Pittsburgh
2012 - NCT03333200 United States
Palliative care
University of Pittsburgh
2012 - NCT03333200 United States
Calico Life Sciences LLC
2023 Phase 1/Phase 2 NCT05757141 Canada;Netherlands;United States
McGill University Health Centre/Research Institute of the McGill University Health Centre
2025 - NCT07300397 Canada
2024 Early Phase 1 NCT07272525 Canada
Hematopoetic stem cell transplantation
University of Pittsburgh
2012 - NCT03333200 United States
Palliative care
University of Pittsburgh
2012 - NCT03333200 United States
